gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
Published 12 years ago • 42 plays • Length 17:28Download video MP4
Download video MP3
Similar videos
-
16:57
gracecast-099_lung-cancer_mm in lc pt 4: broadening use of markers in practice -- panel discussion
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
17:36
gracecast-096_lung-cancer_mm in lc pt 1: dr. charles rudin on the lung cancer mutation consortium
-
24:30
gracecast-100_lung-cancer_mm in lc pt 5: dr. spigel on incorporating targets into clinical trials
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
25:07
gracecast-101_lung-cancer_mm in lc pt6: dr. goss on incorporating markers across a hc system
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
35:02
gracecast-039_lung-cancer_pennell nsclc molecular markers webinar
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
15:50
gracecast-030_lung-cancer_gadgeel on advanced nsclc management
-
1:59:57
grace - global resource for advancing cancer education live stream
-
10:43
gracecast-007_lung-cancer_optimal treatment of unresectable locally advanced nsclc
-
21:32
gracecast 154 lung_dr. wozniak pt 2 sclc current and future treatments
-
9:01
gracecast-040_lung-cancer_horton interview 3 - molecular markers
-
4:20
lung cancer video library - gubens - what is tumor mutational burden in lung cancer management?
-
13:44
gracecast-079_lung-cancer_challenging cases in lung cancer: unresectable locally advanced nsclc
-
12:33
gracecast-025_lung-cancer_questions and trials for nsclc
-
9:49
gracecast-001_lung-cancer_first line chemo for advanced nscl
-
17:58
gracecast-058_lung-cancer_expert round table - stage iiia n2 node-positive options